← All organizations

Sellas Life Sciences Group

For profit

Also known as: Sellas Life Sciences Group | SELLAS Life Sciences Group, Inc. | Selles Life Sciences Group

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jan 31, 2020

Acquired by Galena Biopharma, Inc. → Sellas on Aug 14, 2017

Timeline

2000s

Jun 1, 2006
Sellas Life Sciences Group— Founded

2010s

Aug 1, 2017
Sellas— Now
Aug 14, 2017
Galena Biopharma, Inc.— Acquired By

Drugs by trial phase (2 distinct, 3 trials)

Phase 3 (1 own, 0 via acquisition)

galinpepimut-s

Phase 2 (1 own, 0 via acquisition)

pembrolizumab

Indications

Studied for

Recent trials (5)

NCT05593185Lead sponsorN/A—
NCT04229979Lead sponsorPhase 3Jan 31, 2020
NCT04229979Study directorPhase 3Jan 31, 2020
NCT03761914Study directorPhase 1/Phase 2Jun 30, 2019
NCT03761914Lead sponsorPhase 1/Phase 2Jun 30, 2019

Details

Founded: Hamilton, BM Jun 1, 2006
Last known activity: Jan 31, 2020